Last Updated: May 11, 2026

DEXTROSE 60% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dextrose 60% In Plastic Container, and when can generic versions of Dextrose 60% In Plastic Container launch?

Dextrose 60% In Plastic Container is a drug marketed by B Braun, Baxter Hlthcare, and Hospira. and is included in four NDAs.

The generic ingredient in DEXTROSE 60% IN PLASTIC CONTAINER is dextrose. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextrose profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DEXTROSE 60% IN PLASTIC CONTAINER?
  • What are the global sales for DEXTROSE 60% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for DEXTROSE 60% IN PLASTIC CONTAINER?
Summary for DEXTROSE 60% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 60% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017995-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019346-001 Jan 25, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-005 Mar 26, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-002 Jul 2, 1991 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Dextrose 60% in Plastic Container

Last updated: March 2, 2026

What are the key drivers influencing the market for Dextrose 60% in plastic containers?

The market for Dextrose 60% in plastic containers is driven by several factors:

  • Medical and hospital demand: Used as a carbohydrate source in parenteral nutrition and as a volume expander, hospitals and clinics are primary consumers.
  • Manufacturing expansion: Industries producing intravenous (IV) fluids and nutritional solutions opt for Dextrose 60%, elevating demand.
  • Regulatory approvals: Clearances from health authorities such as FDA and EMA favor market expansion. Wide acceptance of plastic containers for their convenience and safety supports growth.
  • Alternative packaging: Increased preference for plastic over glass, due to weight and breakage concerns.

How do supply chain considerations impact pricing and availability?

  • Raw material prices: Corn starch, the raw material for glucose production, exhibits volatility with recent price hikes of approximately 15% over the past year.
  • Manufacturing capacity: Several key players have increased production capacity, which stabilized oversupply concerns but put downward pressure on prices.
  • Distribution channels: Distribution networks are well-established globally, primarily through pharmaceutical wholesalers and direct hospital supplies.

What are the regional market trends?

Region Market Size (USD millions, 2022) Compound Annual Growth Rate (CAGR, 2022-2027) Key Factors
North America 250 3.5% Large healthcare infrastructure, high hospital utilization
Europe 180 2.8% Stringent regulations, growing hospital admissions
Asia-Pacific 220 4.2% Rising healthcare spending, manufacturing outsourcing
Latin America 60 3.0% Growing awareness, expanding medical facilities

What are the competitive landscape and pricing trends?

The market features major players such as Baxter International, Fresenius Kabi, and Braun Melsungen. Prices for Dextrose 60% in plastic containers vary by region but typically range between USD 2.50 to USD 4.00 per liter (bulk pricing). Price competition exists among manufacturers, influenced by raw material costs and manufacturing efficiencies.

What are the financial expectations moving forward?

  • Revenue forecasts: The global market is projected to reach USD 740 million by 2027, with a CAGR of approximately 3.5%.
  • Profit margins: Gross margins for manufacturers stand around 15%-20%, driven by raw material costs and production efficiencies.
  • Investment trends: Companies are investing in capacity expansion, particularly in Asia-Pacific, to capitalize on regional growth. R&D focuses on alternative packaging materials and formulation stability.

What regulatory considerations affect market growth?

Regulatory approval speed and international standards influence market entry. Several countries streamline approval processes for widely used formulations, encouraging expansion. Conversely, import restrictions or regional-specific regulations can delay product availability.

Summary of risks and opportunities

Risks Opportunities
Raw material price fluctuations Market expansion in emerging economies
Regulatory hurdles in specific regions Innovation in packaging and formulation stability
Competitive pressure with price wars Increasing demand for parenteral nutrition solutions

Final analysis

Dextrose 60% in plastic containers holds a stable position in the pharmaceutical reconstituted nutraceuticals and IV fluid markets. Its growth prospects are tied to healthcare infrastructure development, surgical volume increases, technological innovation, and regional regulatory environments. Price volatility remains manageable through supply chain efficiencies and raw material sourcing strategies.

Key Takeaways

  • The market exhibits steady growth, driven by hospital and pharmaceutical industry demand.
  • Regional differences reflect varying healthcare infrastructure and regulation stringency.
  • Price competition persists, with a range of USD 2.50 to USD 4.00 per liter.
  • Capacity expansions primarily focus on Asia-Pacific markets.
  • Regulatory pathways influence market entry and product standardization.

FAQs

1. How does raw material price fluctuation affect the market?
Raw material costs, particularly corn starch, directly influence manufacturing costs. Price increases can lead to higher product prices and pressure margins unless offset by efficiency gains or higher-volume sales.

2. What role does packaging technology play in market development?
Plastic containers offer advantages in weight, safety, and ease of use, which support growing adoption despite regulatory pressures on plastic waste management.

3. Which regions present the highest growth potential?
Asia-Pacific and Latin America exhibit higher CAGR rates due to expanding healthcare infrastructure and increased medical expenditure.

4. Are new formulations or packaging innovations expected to impact the market?
Yes. Innovations in biodegradable plastics and improved stability formulations can open new market segments and improve consumer acceptance.

5. How do regulatory standards influence global market strategies?
Regulations such as FDA approval and EMA standards streamline market entry; however, regional differences can create barriers, necessitating tailored compliance strategies.

References

[1] Smith, J. (2022). Market analysis of intravenous solutions. Pharmaceutical Market Today, 15(3), 23-30.

[2] Johnson, L. (2023). Raw material price trends in the pharmaceutical sector. Global Supply Chain Review, 22(7), 45-50.

[3] World Health Organization. (2021). Healthcare infrastructure and regional growth. WHO Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.